Impact of Unapproved Drug Initiative on Colchicine Use

Impact of Unapproved Drug Initiative on Colchicine Use

Measure if FDA regulation of Colchicne in 2009 has resulted in safer use in clinical settings.

Our study will assess the impact of this Initiative on colchicine use and will provide data that supports its continuation and expansion.

Inclusion Criteria:

• Clinical diagnosis of gout
• Current use of colchicine/colcrys to treat gout
• Ablility to provide Informed consent

Exclusion Criteria:

-Inability to provide Informed consent